Last reviewed · How we verify

NCT06349720

Investigating Long-term Health Effects and Complications in COVID-19 Recoveries

Recruiting now Last updated 5 April 2024
What this trial tests

trial testing respiratory rehabilitation in COVID-19 Patients in 17,000 participants. Currently enrolling.

Timeline
7 June 2023
Primary endpoint
7 June 2024
7 June 2024

Quick facts

Lead sponsorZhaohui Tong
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment17,000
Start date7 June 2023
Primary completion7 June 2024
Estimated completion7 June 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Zhaohui Tong

Who can join

Adults 18 to 120, any sex, with COVID-19 Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Clarify the incidence of functional impairments in cured COVID-19 patients and identify influencing factors. Build a multi-omics database for COVID-19 patients in the recovery period to elucidate the biological biomarkers and targets associated with functional impairments. Comprehensive exploration of the long-term prognosis, complications, sequelae, and risk factors of COVID-19 patients after Omicron infection, as well as their immune characteristics. Compare the impact of different strains of the COVID-19 virus on prognosis and immune response. Develop comprehensive rehabilitation intervention strategies for COVID-19 patients with functional impairments and evaluate the impact of different intervention methods on their prognosis. Based on clinical data, multi-omics data, and precise rehabilitation assessment data, construct predictive models for prognosis and rehabilitation effectiveness in COVID-19, providing scientific evidence for the implementation of effective COVID-19 rehabilitation measures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of respiratory rehabilitation

Trials testing the same drug.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06349720.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing